Company profile for GlycoNex

GlycoNex

NEW Drugs in Dev: 5

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

Contact Supplier

Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-m-2026-04-20

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

16 News #PharmaBuzz

media
16 News #PharmaBuzz

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GlycoNex Inc. is a pioneering Taiwanese biotechnology company. Through a collaboration with the Biomembrane Institute (TBI) and Dr. Sen-itiroh Hakomori in the US, GlycoNex became a leader in developing cancer therapies. The company combines advanced "glycosphingolipid antigen" and "human monoclonal antibody (mAb) technologies" to create innovative cancer drugs. By integrating these technologies, GlycoNex is at the forefront of...

GlycoNex Inc. is a pioneering Taiwanese biotechnology company. Through a collaboration with the Biomembrane Institute (TBI) and Dr. Sen-itiroh Hakomori in the US, GlycoNex became a leader in developing cancer therapies. The company combines advanced "glycosphingolipid antigen" and "human monoclonal antibody (mAb) technologies" to create innovative cancer drugs. By integrating these technologies, GlycoNex is at the forefront of developing targeted treatments that aim to improve patient outcomes in oncology.

PEGS Boston SummitPEGS Boston Summit

Not Confirmed

Not Confirmed

11 May-15 November, 2026

Massachusetts, U.S.A
DIA Global Annual Meet...DIA Global Annual Meeting

Not Confirmed

Not Confirmed

14-18 June, 2026

Philadelphia, U.S.A
Discovery EuropeDiscovery Europe

Not Confirmed

Not Confirmed

15-16 June, 2026

Berlin, Germany

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Country

Country

Taiwan

Address

Address

8F., No.97, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.glyconex.com.tw/

Linkedin

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

GlycoNex Reports Positive Phase III Results for SPD8 Biosimilar

11 Jun 2026

// PR NEWSWIRE

Glyconex Gets PMDA Nod For First Human Ph1 Trial Of GNX1021

14 Apr 2026

// PR NEWSWIRE

Glyconex, Nippon Kayaku Collaborate on Next-Gen GNX201-ADC

23 Mar 2026

// PR NEWSWIRE

Glyconex Inks CDMO Deal With Change Cure For Hmgb1 Antibody

08 Dec 2025

// PR NEWSWIRE

GlycoNex and Hokkaido University Hospital Launch Study

24 Nov 2025

// PR NEWSWIRE

GlycoNex Announces Last Patient Dosed in Phase 3 Trial of SPD8

29 Oct 2025

// PR NEWSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search